Related Experiment Video
Updated: Apr 4, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
The intestinal microbiome in human disease and how it relates to arthritis and spondyloarthritis
Mary-Ellen Costello1, Philip C Robinson2, Helen Benham3
1The University of Queensland, The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Woolloongabba, Brisbane, QLD, 4102, Australia.
Abstract:
Humans and microbes have developed a symbiotic relationship over time, and alterations in this symbiotic relationship have been linked to several immune mediated diseases such as inflammatory bowel disease, type 1 diabetes and spondyloarthropathies. Improvements in sequencing technologies, coupled with a renaissance in 16S rRNA gene based community profiling, have enabled the characterization of microbiomes throughout the body including the gut. Improved characterization and understanding of the human gut microbiome means the gut flora is progressively being explored as a target for novel therapies including probiotics and faecal microbiota transplants. These innovative therapies are increasingly used for patients with debilitating conditions where conventional treatments have failed. This review discusses the current understanding of the interplay between host genetics and the gut microbiome in the pathogenesis of spondyloarthropathies, and how this may relate to potential therapies for these conditions.
Insights
Alterations in the human gut microbiome are linked to immune-mediated diseases like spondyloarthropathies. This review explores host genetics, gut microbiome interactions, and potential therapies for these conditions.
Area of Science:
- Microbiome research
- Immunology
- Genetics
Background:
- The human microbiome plays a crucial role in health and disease.
- Dysbiosis, or imbalance in the gut flora, is associated with immune-mediated conditions.
- Spondyloarthropathies are a group of inflammatory diseases linked to immune system dysfunction.
Purpose of the Study:
- To review the current understanding of the interplay between host genetics and the gut microbiome in spondyloarthropathies.
- To explore how this interaction influences disease pathogenesis.
- To discuss potential therapeutic strategies targeting the gut microbiome.
Main Methods:
- Literature review of current research on host genetics, gut microbiome, and spondyloarthropathies.
- Analysis of sequencing technologies and 16S rRNA gene profiling in microbiome characterization.
- Examination of novel therapies like probiotics and fecal microbiota transplantation.
Main Results:
- Host genetics and gut microbiome composition are intricately linked in the development of spondyloarthropathies.
- Specific microbial communities and genetic factors contribute to disease pathogenesis.
- Emerging therapies show promise in modulating the gut microbiome for treatment.
Conclusions:
- Understanding the host-gut microbiome axis is critical for deciphering spondyloarthropathies.
- Targeting the gut microbiome offers a promising avenue for novel therapeutic interventions.
- Further research is needed to fully elucidate these complex interactions and optimize treatments.
More Related Videos
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
05:28Analysis of Fecal Microbiota Dynamics in Lupus-Prone Mice Using a Simple, Cost-Effective DNA Isolation Method
Published on: May 2, 2022
Related Concept Videos
Introduction to the Human Microbiota
The Oral Microbiota
Development of Human Microbiota
Functions of the Gut Microbiota
Microbiome of the Eye
Microbiota of the Respiratory Tract